Delisting riskPopularity #3,847
Context Therapeutics (CNTX)
Develops CD3-directed bispecific antibodies for solid tumors.
$0.3858
vs last close−0.00 (−0.85%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
estimated · in 42 days
EPS estimate
−$0.09
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.04−$0.05−$0.09−$0.10−$0.14−$0.09−$0.15Pending
Estimate−$0.05−$0.05−$0.06−$0.09−$0.11−$0.12−$0.09−$0.09
Surprise+20.0%0.0%−50.0%−11.1%−27.3%+25.0%−62.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————−$1.5M———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.15 | — | — |
| Sep 2028 | −$0.15 | — | — |
| Jun 2028 | −$0.15 | — | — |
| Mar 2028 | −$0.14 | — | — |
| Dec 2027 | −$0.11 | — | — |
| Sep 2027 | −$0.10 | — | — |
| Jun 2027 | −$0.10 | — | — |
| Mar 2027 | −$0.10 | — | — |
| Dec 2026 | −$0.11 | — | — |
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.09 | −$0.15 | −62.8% |
| May 2026 | −$0.12 | −$0.09 | +25.0% |
| Mar 2026 | −$0.11 | −$0.14 | −27.3% |
| Nov 2025 | −$0.09 | −$0.10 | −11.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.15 | — | — | $9.5M | — | — | — |
| Sep 2028 | −$0.15 | — | — | $9.1M | — | — | — |
| Jun 2028 | −$0.15 | — | — | $9.1M | — | — | — |
| Mar 2028 | −$0.14 | — | — | $8.8M | — | — | — |
| Dec 2027 | −$0.11 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.10 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.10 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.10 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.11 | — | — | $0 | — | — | — |
| Nov 4, 2026 | −$0.09 | — | — | $0 | — | — | — |
| Aug 5, 2026 | −$0.09 | −$0.15 | −62.8% | — | — | — | −27.3% |
| May 6, 2026 | −$0.12 | −$0.09 | +25.0% | — | — | — | −1.2% |
| Mar 19, 2026 | −$0.11 | −$0.14 | −27.3% | −$1.5M | — | — | +2.4% |
| Nov 5, 2025 | −$0.09 | −$0.10 | −11.1% | — | — | — | +1.8% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 23, 2022 | |||||||
| Dec 2, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |